CANCER-LINKED GENE AS TARGET FOR CHEMOTHERAPY

Details for Australian Patent Application No. 2003218014 (hide)

Owner AVALON PHARMACEUTICALS

Inventors HORRIGAN, Stephen, K.; YOUNG, Paul, E.; EBNER, Reinhard

Pub. Number AU-A-2003218014

PCT Number PCT/US03/07082

PCT Pub. Number WO2003/076587

Priority 60/362,419 07.03.02 US

Filing date 6 March 2003

Wipo publication date 22 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/362,419 07.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-A-2003218014

25 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218015-RADIATION DURABLE ORGANIC COMPOUNDS WITH HIGH TRANSPARENCY IN THE VACUUM ULTRAVIOLET, AND METHOD FOR PREPARING

2003218013-EFFECT OF TREATMENT WITH 4,5-DIHYDROXY2-CYCLOPENTEN-1-ONE (DHCP) ON GENE EXPRESSION AND QUORUMSENSING IN BACTERIA